Market Research Report
Infectious Disease Diagnostics - Global Market Outlook (2017-2026)
|Published by||Stratistics Market Research Consulting||Product code||879127|
|Published||Content info||158 Pages
Delivery time: 2-3 business days
|Infectious Disease Diagnostics - Global Market Outlook (2017-2026)|
|Published: June 19, 2019||Content info: 158 Pages||
According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $14.82 billion in 2017 and is expected to reach $25.90 billion by 2026 growing at a CAGR of 6.4% during the forecast period. Some of the key factors influencing the market are increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases. However, lack of skilled technicians/professionals and high cost of these devices hampers the market growth of bacterial disease diagnostics market.
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.
Based on Application, Central Nervous System (CNS) Infections is expected to grow at a significant rate during the forecast period. Central nervous system infections caused by bacteria or fungi can lead to a brain abscess or bacterial meningitis. Central nervous system infections caused by viruses can lead to viral meningitis or encephalitis. By Geography, North America is anticipated to exhibit the considerable growth due to various government initiatives and easy accessibility to technologically advanced instruments in this region.
Some of the key players in Global Infectious Disease Diagnostics market are Abbott, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Inc. (Gen Probe), PerkinElmer Inc., QIAGEN Group, Quidel Corporation, Roche Diagnostics and Siemens Healthcare.